Dario A. Paggiarino - 14 Jun 2021 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Chief Medical Officer
Signature
/s/ Ron Honig, Attorney-in-Fact
Issuer symbol
EYPT
Transactions as of
14 Jun 2021
Net transactions value
-$4,053
Form type
4
Filing time
15 Jun 2021, 17:04:02 UTC
Next filing
23 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYPT Common Stock Options Exercise $0 +1,420 +12% $0.000000 13,012 14 Jun 2021 Direct
transaction EYPT Common Stock Tax liability $4,053 -417 -3.2% $9.72 12,595 14 Jun 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Restricted Stock Units Options Exercise $0 -1,420 -100% $0.000000* 0 14 Jun 2021 Common Stock 1,420 $0.000000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F2 Vests in three annual installments beginning on 14-Jun-2019